Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
The panel of ministers tasked with the mandate to finalise the country’s drug pricing policy is expected to decide the crucial policy as early as next week after the apex court slammed the government for sitting on it for almost a decade. Two government officials familiar with the development said …
The Supreme Court on Tuesday came down heavily on the Central government for delay in finalising a new drug-pricing policy which will determine prices at which pharma companies can sell essential medicines in the retail market. The apex court, while observing that the government might not find it appropriate if …
The government has allowed 100 per cent FDI in brownfield pharmaceutical projects. To encourage the needed foreign investment in the sector, the finance ministry has cleared eight projects worth over Rs 1,800 crore putting in only conditions like minimum investment in R&D; for investors to comply with. The approval puts …
The national strategic plan for TB control for 2012-17 developed by the Union Ministry of Health & Family Welfare has raised the bar for tackling the fast- growing TB epidemic in the country. The main goal of the strategic plan is to provide universal access to early diagnosis and effective …
The Jan Swasthya Abhiyan on Monday called upon the Union Government to extend free medicine supply scheme, presently operational in a few States like Rajasthan and Tamil Nadu, all over the country to reduce out-of-pocket expenditure of common people on health care. Such a scheme would especially benefit the patients …
KOLKATA, 10 SEPT: Indian scientists have found a safe orally-administered drug against kala-azar, a disease that puts at risk an estimated 165.4 million people in Bihar, Jharkhand, West Bengal and Uttar Pradesh. Termed by the World Health Organisation (WHO) a "neglected disease,” kala-azar or visceral leishmaniasis, the second-largest parasitic killer …
New Delhi: The world’s first effective vaccine against dengue could be available by 2015. Scientists on Tuesday announced a major dengue vaccine breakthrough, with a candidate vaccine showing a 60%-90% protection rate against three virus strains (DENV 1, 3 and 4) that causes the mosquito-borne disease. The vaccine CYD-TDV was …
The fifth Joint Monitoring Mission (JMM) of India and the World Health Organisation (WHO) on the Revised National Tuberculosis Control Programme (RNTCP) has endorsed the National Strategic Plan (NSP) for TB control for 2012-17. The JMM lauded the Government’s efforts in TB control but cautioned that successful implementation of the …
Concerned over the ill effects of Stavudine d4T, a first-line drug against HIV for long, the Centre plans to replace it with safer and better-tolerated Tenofovir and Zidovudine. Stavudine has been linked to high toxicity, adverse effects on cholesterol metabolism, painful neuropathy, pancreatitis, sunken cheeks and buffalo humps. In a …
New Delhi: Over-the-counter sale of around 92 antibiotic and anti-tuberculosis drugs in India will be restricted soon. Drug Controller General of India G N Singh has written to the Union health minister to notify a new schedule, H1, in the Drugs and Cosmetics Rules. Once notified, following clearance from the …
Kerala's famed Ayurveda world is aghast. For neem, a plant known as sarvarogasamhari (panacea) in Ayurveda, is to be included by the Association of Southeast Asian Nations (ASEAN) on its Negative Ingredient List, ostensibly to conserve it. Ayurveda practitioners say the prolific neem doesn't need any conservation. "It's not endangered. …
Cos which have taken corrective action after being penalised for violating FDA norms have been allowed to resume sales Most Indian drug companies that were penalised for violating US drug manufacturing norms in the last few years but have subsequently taken corrective actions are being allowed to resume sales by …
New study reveals alarming levels in Africa, Asia, Europe and Latin America that are resistant to four powerful antibiotics Prevalence of extensively drug-resistant tuberculosis (XDR- TB) is increasing due to expanded use of second-line drugs in people suffering from multidrug-resistant (MDR) diseases, reveals a new study. This large, prospective study …
Scientists claim to have discovered a drug that could cure all strains of malaria with a single oral dose and also block transmission of the deadly parasite from person to person. The compound from the aminopyridine class (code named MMV390048) shows potent activity against multiple points in the malaria parasite’s …
Mumbai: In yet another instance of India Inc occupying a larger seat in the global league tables, three out of the top 10 fastest-growing generic companies globally are now from India. Besides being an indication of the acceptance of domestic pharmaceutical companies and their growing clout, this is also a …
There’s widespread scare over clinical trials and their impact on ill-informed patients, who are often victims of circumstances than willing collaborators in research. This was foreseen long back, which is why medical fraternity brought out the Helsinki Declaration: “Concern for interests of subjects must prevail over interests of science and …
14 New Drug Molecules Approved Between Jan & July 2012, Only 9 Tested: Azad New Delhi: Drugs continue to be approved in India without having undergone proper clinical trials on the local population. Just months after the parliamentary standing committee on health exposed how the country’s highest office on drugs— …
Lack of compensation norms for clinical trials results in exploitation of poor patients Drug companies paid as little as . 50,000 as compensation to families of volunteers who died during clinical trials for new medicines last year, leading to sharp criticism about the paltry sums being handed out and growing …
Alarmed by the rise in illegal drug trials in the country and the lack of effective laws for their monitoring, the National Human Rights Commission (NHRC) is mulling guidelines for clinical trials. The NHRC has written to the Indian Council of Medical Research (ICMR) and other premier medial institutes in …
Novartis patent case up for hearing this week; judgment to have far-reaching impact Mumbai/London: The Supreme Court will hear final arguments starting this week in a landmark case over drug patents that could change the rules for the country's healthcare sector and potentially curb its global role as a supplier …
